Hetero-bivalent Nanobodies Provide Broad-spectrum Protection against SARS-CoV-2 Variants of Concern including Omicron
T. Jin, H. Ma, X. Zhang, P. Zheng, P. H. Dube, W. Zeng, S. Chen, Y. Yang, Y. Wu, J. Zhou, X. Hu, Y. Xiang, H. Zhang, S. Chiu
This paper develops hetero-bivalent nanobodies that neutralize multiple SARS-CoV-2 variants, including Omicron, and show protective effects in vivo.
bioRxiv · Mar 8, 2022Immunology